The U.S. Food and Drug Administration has reinforced its safety warnings concerning heart-attacks and risks of stroke that is associated with a class of widely used pain relieving medicines like Celebrex, Advil, Aleve and Motrin IB.
According to the latest data of FDA, it has been concluded that medicines known as NSAIDs, for non-steroidal anti-inflammatory drugs most definitely causes a heightened risks of stroke and heart attacks. For a very long time now, it has required a warning on the class of drugs which said that they “may cause” an enhanced risk.
The agency will make it mandatory for the makers of prescription versions of the medication to change their labels. The change will also be including the statement which may be displayed that all through the whole course of using NSAID there are risks involved, even in the first weeks of treatment.
The FDA has also said that it would be requesting that the drugmakers of the over-the-counter to make changes as such in the upcoming months to the Drug Facts labels. The regulatory procedure of the changing prescription drugs and over-the-counter levels are different.
The class is also inclusive of generic ibuprofen, naproxen, diclofenac and meloxicam.
The agency has also emphasized that the increased risk “most often occurs at higher doses.” According to the Consumer Healthcare Products Association, representing the manufacturers of over-the-counter versions of the drugs stated that people usually take these medicines at much lower doses and in short-term dosages, rather than for chronic conditions.
There is also a heightened risk of heart failure associated with NSAIDs and the patients who had taken them after their first heart attack had more chances of losing their lives within the first year compared to patients who hadn’t received treatments using that same class of drugs.
The FDA has also stated that the new safety information does not permit it to say if any drugs in the class are safer in comparison to others.
